Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort

Colaboración

Año: 2017

Husing, A; Fortner, RT; Kuhn, T; Overvad, K; Tjonneland, A; Olsen, A; Boutron-Ruault, MC; Severi, G; Fournier, A; Boeing, H; Trichopoulou, A; Benetou, V; Orfanos, P; Masala, G; Pala, V; Tumino, R; Fasanelli, F; Panico, S; de Mesquita, HBB; Peeters, PH; van Gills, CH; Quiros, JR; Agudo, A; SAnchez, MJ; Chirlaque, MD; Barricarte, A; Amiano, P; Khaw, KT; Travis, RC; Dossus, L; Li, KR; Ferrari, P; Merritt, MA; Tzoulaki, I; Riboli, E; Kaaks, R

Título: CLINICAL CANCER RESEARCH

• D1